Status:
UNKNOWN
Nasogastric Tube in Pancreatic Surgery
Lead Sponsor:
Tongji Hospital
Conditions:
Nasogastric Tube Decompression
Pancreatic Surgery
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Introduction: The value of routine nasogastric tube (NGT) decompression after pancreatic surgeries is not yet established. Previous studies in the setting of abdominal surgery suggested that the use o...
Eligibility Criteria
Inclusion
- Patients with age between 18 - 80 years.
- Patients underwent any kind of pancreatic surgeries, including but not limited to PD, distal pancreatectomy, central pancreatectomy, pancreatic enucleation, etc.
- Patients accepted the trial and could completed a written consent.
Exclusion
- Combined with digestive tract obstruction before the surgery.
- History of upper abdominal surgery.
- Serious heart, brain, lung, metabolic diseases history.
- Pregnant women.
- Unwillingness or inability to consent for the study.
Key Trial Info
Start Date :
May 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03462602
Start Date
May 1 2018
End Date
May 1 2021
Last Update
March 12 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tongji Hospital
Wuhan, Hubei, China, 430000